Management of BCG lymphadenitis.
- Author:
Jung Tak OH
1
;
In Gyu KIM
;
Seok Joo HAN
;
Eui Ho HWANG
Author Information
1. Division of Pediatric Surgery, Department of Surgery Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Bacillus Calmette-Guerin;
Lymphadenitis;
Antituberculous medication
- MeSH:
Bacillus;
Curettage;
Humans;
Lymphadenitis*;
Mycobacterium bovis*;
Recurrence;
Retrospective Studies;
Vaccination
- From:Journal of the Korean Association of Pediatric Surgeons
1997;3(2):143-147
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Bacillus Calmette-Guerin (BCG) lymphadenitis is a complication of post-BCG vaccination and its treatment is still controversial. Eighty patients who were operated for BCG lymphadenitis from 1987 to 1996 are be reviewed retrospectively. Thirty-one of them were treated with antituberculous drugs (mean duration:3 months) preoperatively and 49 patients were not given preoperative antituberculous medication. No one was treated with antituberculous drugs postoperatively. Operation methods were excision (72) and partial excision with curettage (8). There was no statistical significance of recurrence rate between both treatment modalities. In two patients (2.5%) who were treated with preoperative antituberculous drugs and excision, the lesions recurred after operation. The results suggest that preoperative antituberculous medication does not play any role for treatment of BCG lymphadenitis and prevention of recurrence in surgically excised cases.
